Trump’s pharma tariff order is a maze of delays, carve-outs and company-specific rates
The White House’s April 2 pharmaceutical proclamation sets a 100% duty on certain patented drugs and ingredients, but the main tariff provisions do not hit all at once. Annex III companies face the first effective date, July 31, 2026, while other companies fall under the later September 29, 2026 start, and several products and negotiated lanes are carved out entirely.
First recorded Apr 16, 2026·Meaningfully updated Apr 16, 2026
Returning reader
What changed
Trump’s pharma tariff order is a maze of delays, carve-outs and company-specific rates
The White House’s April 2 pharmaceutical proclamation sets a 100% duty on certain patented drugs and ingredients, but the main tariff provisions do not hit all at once. Annex III companies face the first effective date, July 31, 2026, while other companies fall under the later September 29, 2026 start, and several products and negotiated lanes are carved out entirely.
The White House’s April 2 pharmaceutical proclamation sets a 100% duty on certain patented drugs and ingredients, but the main tariff provisions do not hit all at once. Annex III companies face the first effective date, July 31, 2026, while other companies fall under the later September 29, 2026 start, and several products and negotiated lanes are carved out entirely.
Truth standard
What TDF can prove
The linked reports preserve their sources, audit notes, confidence rating, corrections, and comments. The page Q&A below is restricted to those connected materials and will say when the evidence does not establish an answer.